세계 마이크로니들 시장 규모는 2023년 10억 달러에서 예측 기간 동안 5.1%의 CAGR을 기록하며 2028년 말에는 13억 달러 규모로 성장할 것으로 예상됩니다.
고체 마이크로니들 부문은 2023년 4억 6,910만 달러에서 5.2%의 CAGR로 2028년 말에는 6억 580만 달러에 달할 것으로 예측됩니다. 또한, 용해성 마이크로니들 부문은 2023년 1억 610만 달러에서 5.6%의 CAGR로 2028년 말에는 1억 3,950만 달러에 달할 것으로 예측됩니다.
세계의 마이크로니들 시장을 조사했으며, 시장 정의와 개요, 시장 영향요인 및 시장 기회 분석, 규제 환경, 시장 규모 추이 및 예측, 각종 부문별·지역별 상세 분석, 임상시험 및 특허 동향, ESG 전개, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 서론
제2장 요약과 하이라이트
제3장 시장 개요
- 개요
- 실적
- 마이크로니들 재료와 제조
- 마이크로니들 파이프라인
- 규제 상황
- 제품 리콜
제4장 시장 역학
- 시장 성장 촉진요인
- 잠재적 용도
- 피부과 시술 수요 증가
- 감염증 증가
- 최소침습 약물전달에 대한 수요 증가
- 시장 성장 억제요인
- 디바이스 사용 리스크와 제한
- 엄격한 규제 시나리오
- 시장 기회
- 주요 기업에 의한 R&D
- 시장 과제
- 복잡한 제조 공정
- COVID-19의 시장에 대한 영향
제5장 시장 내역 : 마이크로니들 유형별
- 시장 개요
- 시장 점유율과 예측
- 솔리드 마이크로니들
- 중공 마이크로니들
- 용해 마이크로니들
- 코팅 마이크로니들
- 하이드로겔 마이크로니들
제6장 시장 내역 : 용도별
- 시장 개요
- 시장 점유율과 예측
- 피부과
- 면역 생물학적 관리
- 질병 치료
- 질병 진단
제7장 시장 내역 : 지역별
- 세계의 마이크로니들 시장 : 지역별
- 북미
- 미국
- 캐나다
- 유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
- 아시아태평양
- 일본
- 중국
- 인도
- 한국
- 기타 아시아태평양
- 기타 지역
제8장 ESG의 개발
- ESG : 서론
- 마이크로니들 업계의 지속가능성 : ESG의 관점
- ESG의 주요 문제
- 마이크로니들 업계의 ESG 퍼포먼스 분석
- 마이크로니들 시장의 ESG에 대한 소비자 의식
- 사례 연구
- BCC에 의한 결론
제9장 신기술
- 마이크로니들 3D 프린팅 기술
- 마이크로니들에 의한 약물 모니터링
- 식물 병해 관리용 마이크로니들
- 스마트 마이크로니들
- 나노테크놀러지를 통합한 마이크로니들
- 마이크로니들 웨어러블 디바이스로의 통합
제10장 임상시험·특허 분석
- 임상시험 분석
- 임상시험 분석 : 연구 유형별
- 임상시험 분석 : 상황별
- 임상시험 분석 : 단계별
- 임상시험 분석 : 지역별
- 특허 분석
- 특허 : 연도별
- 특허 : 상위 출원인별
- 특허 : 주요 보유자별
- 특허 : 관할구역별
제11장 경쟁 정보
제12장 기업 개요
- BECTON, DICKINSON AND CO.
- CANDELA CORP.
- CLEARSIDE BIOMEDICAL
- COSMED PHARMACEUTICAL CO. LTD.
- CUTERA
- CYNOSURE
- DEBIOTECH SA
- LTS LOHMANN THERAPIE-SYSTEME AG
- MERCATOR MEDSYSTEMS INC.
- MI.TO.PHARM GMBH
- MICROPOINT TECHNOLOGIES
- NANOBIOSCIENCES LLC
- NANOPASS
- THERAJECT INC.
- VAXESS TECHNOLOGIES INC.
제13장 부록 : 두문자어
ksm
Highlights:
The global market for microneedles is expected to grow from $1.0 billion in 2023 to $1.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 5.1% from 2023 through 2028.
The global market for solid microneedles is expected to grow from $469.1 million in 2023 to $605.8 million by the end of 2028, at a CAGR of 5.2% from 2023 through 2028.
The global market for dissolving microneedles is expected to grow from $106.1 million in 2023 to $139.5 million by the end of 2028, at a CAGR of 5.6% from 2023 through 2028.
Report Scope:
The current report provides detailed information about the microneedle market. It highlights the current and future market potential for microneedles and provides a detailed analysis of the drivers, restraints, challenges, and opportunities in the market. The report also covers market projections for 2028 and includes the market rankings of key market players. It also covers the competitive environment and regulatory scenario.
The report details the market share of microneedles based on product and application. Based on product, the market is segmented into solid microneedles, hollow microneedles, coated microneedles, dissolving microneedles, and hydrogel microneedles. Based on application, the market is segmented into disease treatment, immunobiological administration, disease diagnosis, and dermatology applications. Hydrogel and disease diagnosis applications that are covered in the report are not commercially approved and are being used primarily by research organizations.
The market has been divided by geography into North America, Europe, Asia-Pacific, and the Rest of the World. The North American region comprises countries such as the U.S. and Canada; Europe includes Germany, the U.K., Italy, France, Spain, and the Rest of Europe; and Asia-Pacific includes China, India, Japan, South Korea, and the Rest of Asia-Pacific. For market estimates, data has been provided for 2020 and 2021 as the historical years and for 2022 as the base year, with forecasts for 2028.
Report Includes:
- 30 data tables and 37 additional tables
- An overview of the global market for microneedles
- Analysis of the global market trends, featuring historical revenue data for 2020 to 2022, estimated figures for 2023, as well as forecasts for 2028, including projections of compound annual growth rates (CAGRs) through 2028
- Evaluation of the current market size and revenue growth prospects, accompanied by a market share analysis by type, application and geographical region
- A look at the key market dynamics, the industry structure, regulatory landscape, current outlook and an analysis of the COVID-19 impact on the market for medical devices and microneedles
- Discussion of the properties of the latest generation of smart microneedles, such as skin adhesion, dissolvability, responsiveness and tip-substrate detachability, as well as whether they are bionic, bioderived or biocompatible in nature
- Review of patents on microneedle array technologies by assignee and products in the pipeline
- Coverage of evolving technologies, ESG trends and clinical trials
- Competitive benchmarking of key players, categorized by dermatology and vaccine and drug delivery, and their growth strategies
- Profiles of leading market participants
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- What's New in This Report?
- Research Methodology
- Information Sources
- Geographic Breakdown
- Segmentation Breakdown
Chapter 2 Summary and Highlights
- Market Outlook
- Highlights of the Market for Microneedles
Chapter 3 Market Overview
- Overview
- History
- Microneedle Materials and Manufacturing
- Microneedle Pipeline
- Regulatory Landscape
- Product Recalls
Chapter 4 Market Dynamics
- Market Drivers
- Potential Applications of Microneedles
- Rising Demand for Dermatology Procedures
- Increasing Number of Infectious Diseases
- Rising Demand for Minimally Invasive Drug Delivery
- Market Restraints
- Risks and Limitations of Using Microneedling Devices
- Stringent Regulatory Scenario
- Market Opportunities
- R&D of Microneedles by Key Players
- Market Challenges
- Complex Manufacturing Process
- Impact of COVID-19 on the Microneedle Market
Chapter 5 Market Breakdown by Type of Microneedle
- Market Overview
- Market Share and Forecast
- Solid Microneedles
- Hollow Microneedles
- Dissolving Microneedles
- Coated Microneedles
- Hydrogel Microneedles
Chapter 6 Market Breakdown by Application
- Market Overview
- Market Share and Forecast
- Dermatology
- Immunobiological Administration
- Disease Treatment
- Disease Diagnosis
Chapter 7 Market Breakdown by Region
- Global Market for Microneedles by Region
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- South Korea
- Rest of Asia-Pacific
- Rest of the World
Chapter 8 ESG Development
- Introduction to ESG
- Sustainability in Microneedle Industry: An ESG Perspective
- Key ESG Issues
- Microneedle Industry ESG Performance Analysis
- Consumer Attitudes toward ESG in the Microneedle Market
- Case Study
- Concluding Remarks from BCC
Chapter 9 Emerging Technologies
- Introduction
- 3D-Printing Technology in Microneedles
- Drug Monitoring with Microneedles
- Microneedle for Plant Disease Management
- Smart Microneedles
- Nanotechnology-Integrated Microneedles
- Integration of Microneedles into Wearable Devices
Chapter 10 Clinical Trials and Patent Analysis
- Clinical Trial Analysis
- Clinical Trial Analysis, by Type of Study
- Clinical Trial Analysis, by Status
- Clinical Trial Analysis, by Phase
- Clinical Trial Analysis, by Region
- Patent Analysis
- Patents by Year
- Patents by Top Applicant
- Patents by Top Patent Holder
- Patents by Jurisdiction
Chapter 11 Competitive Intelligence
- Market Share Analysis
- Recent Developments of Key Companies
Chapter 12 Company Profiles
- BECTON, DICKINSON AND CO.
- CANDELA CORP.
- CLEARSIDE BIOMEDICAL
- COSMED PHARMACEUTICAL CO. LTD.
- CUTERA
- CYNOSURE
- DEBIOTECH SA
- LTS LOHMANN THERAPIE-SYSTEME AG
- MERCATOR MEDSYSTEMS INC.
- MI.TO.PHARM GMBH
- MICROPOINT TECHNOLOGIES
- NANOBIOSCIENCES LLC
- NANOPASS
- THERAJECT INC.
- VAXESS TECHNOLOGIES INC.
Chapter 13 Appendix: Acronyms
